Browse the full record of transactions filed by Van Tuyl Christopher, Directeur Juridique. Insider active across 1 companies, notably Immunovant, Inc.. Cumulatively, 6 reports have been published. Total volume traded: €734k. The latest transaction was disclosed on 8 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations
Van Tuyl Christopher serves as Chief Legal Officer at Immunovant, Inc. In this role, he is responsible for managing the company's legal affairs, including compliance and risk management. His expertise in business law enables him to provide strategic advice to management and protect the company's interests. Christopher plays a key role in formulating internal policies and managing litigation.